Clinical Trial

Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension

Study acronym: EARLIER
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Measurement of the endtidal carbon dioxide by capnography to exclude or to ensure the diagnosis pulmonary hypertension. The aim of the study is to obtain an endtidal carbon dioxide cut-off value for the diagnostic algorithm for pulmonary hypertension as an easily measurable and cheap diagnostic tool in patients with suspicion of pulmonary hypertension.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2017-12-22; most recent amendment 2022-05-18.
Status change: Active, Not Recruiting → Enrolling by Invitation 2019-09-25
Status change: Not Yet Recruiting → Active, Not Recruiting 2018-05-02
Trial Details
NCT Number NCT03388476
Lead Sponsor University of Giessen
Conditions Hypertension, Pulmonary, Hypertension;Pulmonary;Primary, Chronic Thromboembolic Pulmonary Hypertension, Vascular Diseases, Lung Diseases
Enrollment 500 participants
Start Date 2018-05-02
Primary Completion 2030-01-01 (estimated)
Study Completion 2035-01-01 (estimated)
Updated on ClinicalTrials.gov 2022-05-19